NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) Institutional Ownership

CUSIP: 63937X103

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2019

Type / Class
Equity / COM
Symbol
NAVB on OTC
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2019 Q3 0 $0 -$9,000 0
2019 Q2 0 $0 -$1,406,138 0
2019 Q1 10,256,969 $1,415,138 +$81,465 $0.14 35
2018 Q4 9,755,964 $1,001,000 -$1,540,884 $0.10 41
2018 Q3 12,049,791 $3,904,000 -$57,561 $0.23 44
2018 Q2 12,063,015 $2,758,000 -$222,542 $0.23 42
2018 Q1 12,954,107 $4,661,000 -$33,133 $0.36 48
2017 Q4 13,578,259 $4,923,000 -$138,427 $0.36 49
2017 Q3 13,836,188 $5,757,000 -$19,489 $0.41 50
2017 Q2 13,534,057 $6,907,000 -$167,170 $0.51 47
2017 Q1 13,857,351 $8,004,000 +$1,184,086 $0.58 45
2016 Q4 14,893,662 $9,424,000 -$198,710 $0.64 49
2016 Q3 13,957,985 $12,774,000 -$7,454,788 $0.92 51
2016 Q2 26,888,509 $14,283,000 -$4,830,200 $0.53 58
2016 Q1 49,950,433 $47,172,000 +$4,068,782 $0.94 71
2015 Q4 45,328,798 $60,283,355 -$14,593,507 $1.33 76
2015 Q3 55,473,383 $126,469,266 +$7,073,752 $2.28 80
2015 Q2 52,515,653 $84,544,619 +$4,133,792 $1.61 76
2015 Q1 49,997,195 $79,546,612 +$1,020,513 $1.59 79
2014 Q4 49,194,033 $92,913,806 -$10,321,973 $1.89 83
2014 Q3 55,539,879 $73,445,673 -$354,395 $1.32 80
2014 Q2 55,648,941 $82,330,815 +$1,677,502 $1.48 84
2014 Q1 54,358,844 $100,505,761 +$16,821,410 $1.85 80